Medicine and Dentistry
Pediatrics
100%
Ganglioglioma
61%
Germinoma
46%
Central Nervous System
42%
Tumor
35%
Medulloblastoma
31%
Radiation Therapy
25%
Neuro-Oncology
24%
Neoplasm
24%
Central Nervous System Tumor
22%
Non Seminomatous Germinoma
20%
Craniospinal Irradiation
18%
Diseases
17%
Clinical Trial
17%
Intracranial Tumor
15%
Hematopoietic Cell
15%
Overall Survival
14%
Treatment Modality
14%
Medicine
13%
Atypical Teratoid Rhabdoid Tumor
12%
Malignant Neoplasm
12%
Everolimus
12%
Meta-Analysis
10%
Germ Cell
10%
Pediatric Brain Tumor
10%
Chemotherapy
9%
Induction Chemotherapy
9%
Pilocytic Astrocytoma
8%
Solid Malignant Neoplasm
8%
Recurrent Disease
7%
Oncologist
7%
Cerebrospinal Fluid
7%
Dentigerous Cyst
7%
Childhood Cancer
7%
Disease Predisposition
6%
Ventricle of Heart
6%
Progression Free Survival
6%
Prognostic Factor
6%
Magnetic Resonance Imaging
6%
Neurofibromatosis Type I
6%
Progressive Disease
6%
Mitogen-Activated Protein Kinase
6%
Basal Ganglia
6%
Malignant Rhabdoid Tumour
5%
Event Free Survival
5%
Adverse Event
5%
Intrathecal Drug Administration
5%
G 207
5%
Rosette Formation
5%
Rhabdoid Tumor
5%
Keyphrases
Tumor
35%
Pediatric
34%
Pediatric Low-grade Glioma
31%
Chemotherapy
29%
Central Nervous System
29%
Medulloblastoma
25%
Pediatric Neuro-oncology
24%
Central Nervous System Tumors
24%
Non-seminomatous Germ Cell Tumor (NSGCT)
23%
Older Adults
21%
Relapsed or Refractory
19%
Solid Tumors
18%
Craniospinal Irradiation
18%
Low-grade Glioma
17%
Germinoma
17%
Treatment Strategy
16%
Meta-analysis
16%
BRAF Inhibitor (BRAFi)
16%
Firefly
16%
Pediatric Brain Tumor
15%
Radiotherapy
15%
Irradiation
14%
Treatment Modalities
14%
Clinical Trials
14%
Confidence Interval
14%
Atypical Teratoid Rhabdoid Tumor (AT/RT)
13%
Pediatric Glioma
13%
Survivors
12%
Everolimus
12%
Ablative
12%
Marrow
12%
Tumors in children
11%
Central Nervous System Germ Cell Tumor
11%
Overall Survival
11%
Central Nervous System Germinoma
11%
Multi-institutional Analysis
10%
Young children
10%
Rhabdoid Tumor
10%
Down Syndrome
10%
Glioneuronal Tumor
10%
Glioma Tumor
10%
International Case
10%
MEK Inhibitor (MEKi)
10%
Chemotherapy Regimen
9%
Germ Cell Tumor
9%
Induction Chemotherapy
9%
Radiation Therapy
9%
Hematopoietic Cells
9%
Germ Cells
9%
Pediatric Population
8%